Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyperglycemia exacerbates dengue virus infection by facilitating poly(A)-binding protein–mediated viral translation
Ting-Jing Shen, … , Chia-Yi Yu, Chiou-Feng Lin
Ting-Jing Shen, … , Chia-Yi Yu, Chiou-Feng Lin
Published September 20, 2022
Citation Information: JCI Insight. 2022;7(21):e142805. https://doi.org/10.1172/jci.insight.142805.
View: Text | PDF | Corrigendum
Research Article Infectious disease Virology

Hyperglycemia exacerbates dengue virus infection by facilitating poly(A)-binding protein–mediated viral translation

  • Text
  • PDF
Abstract

Diabetes mellitus (DM) is highly comorbid with severe dengue diseases; however, the underlying mechanisms are unclear. Patients with DM have a 1.61-fold increased risk of developing dengue hemorrhagic fever. In search of host factors involved in dengue virus (DENV) infection, we used high-glucose (HG) treatment and showed that HG increased viral protein expression and virion release but had no effects on the early stages of viral infection. After HG stimulation, DENV–firefly luciferase–transfected assay and cellular replicon–based assay indicated increased viral translation, whereas using the glucose uptake inhibitor phloretin blocked this effect. HG treatment increased the translational factor poly(A)-binding protein (PABP) in a glucose transporter–associated, PI3K/AKT-regulated manner. Silencing PABP significantly decreased HG-prompted virion production. HG enhanced the formation of the PABP–eukaryotic translation initiation factor 4G complex, which is regulated by protein–disulfide isomerase. Hyperglycemia increased PABP expression, mortality rate, viral protein expression, and viral loads in streptozotocin-induced DM mice. Overall, hyperglycemic stress facilitates DENV infection by strengthening PABP-mediated viral translation.

Authors

Ting-Jing Shen, Chia-Ling Chen, Tsung-Ting Tsai, Ming-Kai Jhan, Chyi-Huey Bai, Yu-Chun Yen, Ching-Wen Tsai, Po-Chun Tseng, Chia-Yi Yu, Chiou-Feng Lin

×

Figure 3

Inhibiting glucose uptake reduces HG-enhanced viral translation and virion production.

Options: View larger image (or click on image) Download as PowerPoint
Inhibiting glucose uptake reduces HG-enhanced viral translation and viri...
(A) Glucose (Glu) 5.5 mM medium–maintained BHK-21 cells were cotransfected with DENV-FLuc and pCAG-T7pol after stimulation with medium containing Glu 5.5 or 25 mM for 48 hours. (B) Luciferase activity of DENV-FLuc–containing BHK-21 cells were detected and analyzed. (C) BHK-21 cells were transfected with D2-Fluc-SGR-Neo-1 and selected by G418 addition. (D) The luciferase activity assay showed translation activity in parental BHK-21 and BHK-D2-Fluc-SGR-Neo-1 cells (replicons) treated with the indicated concentrations of Glu for 48 hours. (E) Luciferase activity of replicons was determined with or without Phl treatment for 48 hours. (F) Plaque assays were conducted to determine the viral titer in DENV-infected BHK-21 cells treated with Glu and/or 40 μM Phl. DMSO was used as a control. The mean ± SD of quantitative data from at least 3 independent experiments are reported. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts